Detalhe da pesquisa
1.
The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma.
J Neurooncol;
167(1): 75-88, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38363490
2.
Lymphangioleiomyomatosis as a potent lung cancer risk factor: Insights from a Japanese large cohort study.
Respirology;
2024 Apr 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38654512
3.
High levels of AXL expression in untreated EGFR-mutated non-small cell lung cancer negatively impacts the use of osimertinib.
Cancer Sci;
114(2): 606-618, 2023 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36169649
4.
Disseminated nontuberculous mycobacteriosis and fungemia after second delivery in a patient with MonoMAC syndrome/GATA2 mutation: a case report.
BMC Infect Dis;
21(1): 502, 2021 May 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34051752
5.
A molecular glue RBM39-degrader induces synthetic lethality in cancer cells with homologous recombination repair deficiency.
NPJ Precis Oncol;
8(1): 117, 2024 May 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38789724
6.
Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profiling.
NPJ Precis Oncol;
6(1): 82, 2022 Nov 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36333410
7.
Impact of tumor programmed death ligand-1 expression on osimertinib efficacy in untreated EGFR-mutated advanced non-small cell lung cancer: a prospective observational study.
Transl Lung Cancer Res;
10(8): 3582-3593, 2021 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34584858